日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107

DNA免疫疗法治疗复发性呼吸道乳头状瘤病(RRP):一项评估INO-3107疗效、安全性和免疫原性的1/2期研究

Morrow, Matthew P; Gillespie, Elisabeth; Sylvester, Albert; Amin, Milan R; Belafsky, Peter C; Best, Simon R; Friedman, Aaron D; Klein, Adam M; Lott, David G; Mau, Ted; Paniello, Randal C; Pransky, Seth M; Saba, Nabil F; Tan, Grace S; Wisotsky, Sadie; Marcus, Sarah A; Reuschel, Emma L; Reed, Katherine S; Weiner, David B; Dallas, Michael; Skolnik, Jeffrey M

Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults

在加纳健康成年人中开展的 1b 期临床试验中,研究人员评估了 INO-4500(一种合成 DNA 疫苗,用于预防拉沙病毒)的安全性、耐受性和免疫原性。

Koram, Kwadwo Ansah; Walker, Kathleen A; Orizu, Bonaventure; Marrero, Idania; Boyer, Jean; Yang, ShuPing; Broderick, Kate E; Kusi, Kwadwo Asamoah; Kyei-Baafour, Eric; Ofori, Ebenezer Addo; Pobee, Abigail; Adu-Amankwah, Susan; Amoakoh-Coleman, Mary; Amoakoh, Hannah Brown; Abuaku, Benjamin; Badji, Edem; Ntiri, Michael; Quaye, Lydia; Morrow, Matthew P; Sylvester, Albert J; Reuschel, Emma L; Gillespie, Elisabeth; Liebowitz, David; Humeau, Laurent M

Safety, tolerability, and immunogenicity of a DNA-based vaccine (INO-4700) against Middle East respiratory syndrome coronavirus: phase 2a study in healthy volunteers

DNA疫苗(INO-4700)对抗中东呼吸综合征冠状病毒的安全性、耐受性和免疫原性:健康志愿者中的2a期研究

Agnes, Joseph T; Marcus, Sarah A; Al-Ghraibeh, Sahem S; Al-Sweedan, Suleimman Ahmad; Kosgei, Josphat; Ogutu, Bernhards; Yang, ShuPing; Walker, Kathleen A; Orizu, Bonaventure; Broderick, Kate E; Boyer, Jean; Ramos, Stephanie; Morrow, Matthew P; Kraynyak, Kimberly; Sylvester, Albert J; Gillespie, Elisabeth; Liebowitz, David; Humeau, Laurent M

FRI057 Drug Concentrations And Dosing Considerations For Mibavademab, A Novel Leptin Receptor Agonist, In Individuals With Generalized Lipodystrophy

FRI057 药物浓度和剂量考虑因素:Mibavademab(一种新型瘦素受体激动剂)在全身性脂肪营养不良患者中的应用

Popova, Inna E; Bair, Daniel A; Tate, Kenneth W; Parikh, Sanjai J; Foss de Freitas, Maria Cristina; DillGomes, Anabela; Neidert, Adam; Podgrabinska, Simona; Olenchock, Ben; SinhaRoy, Rababir; Harris, Charles Andrew; Akinci, Baris; Altarejos, Judith; Oral, Elif A; Tebas, Pablo; Agnes, Joseph; Giffear, Mary; Kraynyak, Kimberly A; Blackwood, Elliott; Amante, Dinah; Reuschel, Emma; Liu, Neiman; Purwar, Mansi; Christensen-Quick, Aaron; Andrade, Viviane M; Carter, Julie; Garufi, Gabriella; Diehl, Malissa; Sylvester, Albert; Morrow, Matthew P; Pezzoli, Patrick P; Kulkarni, Abhijeet J; Zaidi, Faraz I; Frase, Drew; Liaw, Kevin; Patel, Ami; Buttigieg, Karen R; Ervin, John E; Pawlicki, Jan; Gillespie, Elisabeth; Maricic, Igor; Schultheis, Katherine; Badie, Hedieh; Herring, Timothy A; Simon, Keiko O; Smith, Trevor R F; Ramos, Stephanie; Spitz, Robert; Lee, Jessica; Dallas, Michael; Brown, Ami Shah; Shea, Jacqueline E; Kim, J Joseph; Weiner, David; Broderick, Kate; McMullan, Trevor; Boyer, Jean; Humeau, Laurent; Mammen Jr., Mammen P; Mendell, Jeanne; Wang, Yuhuan; Olenchock, Ben A; Podgrabinska, Simona; Pagovich, Odelya E; Oral, Elif A; Brown, Rebecca J; Davis, John

Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors

一项针对成人实体瘤患者,评估人端粒酶(hTERT)编码DNA质粒INO-1400和INO-1401联合或不联合IL-12 DNA质粒INO-9012的安全性、耐受性和免疫原性的I期研究

Vonderheide, Robert H; Kraynyak, Kimberly A; Shields, Anthony F; McRee, Autumn J; Johnson, Jennifer M; Sun, Weijing; Chintakuntlawar, Ashish V; Pawlicki, Jan; Sylvester, Albert J; McMullan, Trevor; Samuels, Robert; Kim, Joseph J; Weiner, David; Boyer, Jean D; Morrow, Matthew P; Humeau, Laurent; Skolnik, Jeffrey M

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial.

INO-4800 DNA疫苗对SARS-CoV-2的安全性和免疫原性:一项开放标签1期临床试验的初步报告

Tebas Pablo, Yang ShuPing, Boyer Jean D, Reuschel Emma L, Patel Ami, Christensen-Quick Aaron, Andrade Viviane M, Morrow Matthew P, Kraynyak Kimberly, Agnes Joseph, Purwar Mansi, Sylvester Albert, Pawlicki Jan, Gillespie Elisabeth, Maricic Igor, Zaidi Faraz I, Kim Kevin Y, Dia Yaya, Frase Drew, Pezzoli Patrick, Schultheis Katherine, Smith Trevor R F, Ramos Stephanie J, McMullan Trevor, Buttigieg Karen, Carroll Miles W, Ervin John, Diehl Malissa C, Blackwood Elliott, Mammen Mammen P, Lee Jessica, Dallas Michael J, Brown Ami Shah, Shea Jacqueline E, Kim J Joseph, Weiner David B, Broderick Kate E, Humeau Laurent M

578. INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants

578. INO-4800 DNA疫苗可诱导针对全球SARS-CoV-2变异株的中和抗体和T细胞活性

Huangfu, Yonghao; Li, Qingshan; Yang, Weiwei; Bu, Qingwei; Yang, Lei; Tang, Jianfeng; Gan, Jie; Andrade, Viviane M; Christensen-Quick, Aaron; Agnes, Joseph; Tur, Jared; Reed, Charles C; Kalia, Richa; Marrero, Idania; Elwood, Dustin; Schultheis, Katherine; Purwar, Mansi; Reuschel, Emma; McMullan, Trevor; Pezzoli, Patrick; Kraynyak, Kimberly A; Sylvester, Albert; Mammen Jr., Mammen P; Tebas, Pablo; Kim, J Joseph; Weiner, David; Smith, Trevor R F; Ramos, Stephanie; Humeau, Laurent; Boyer, Jean; Broderick, Kate

LTBK-04. PHASE 2 MULTICENTER STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 (TASADENOTUREV) IN COMBINATION WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)

LTBK-04. 溶瘤腺病毒 DNX-2401 (TASADENOTUREV) 联合帕博利珠单抗治疗复发性胶质母细胞瘤的 II 期多中心研究;封闭式研究 (KEYNOTE-192)

Niu, Xiaodong; Yang, Yuan; Zhou, Xingwang; Zhang, Haodongfang; Zhang, Yuekang; Liu, Yanhui; Mao, Qing; Soffietti, Riccardo; Viapiano, Mariano; Hegi, Monika; Ghosh, Sourav; Purow, Benjamin; Reardon, David A; Brem, Steven; Desai, Arati Suvas; Bagley, Stephen Joseph; Kurz, Sylvia Christine; De La Fuente, Macarena Ines; Nagpal, Seema; Welch, Mary Roberta; Hormigo, Adilia; Forsyth, Peter; Mandell, Jacob; Khagi, Simon; Aiken, Robert; Walbert, Tobias; Lieberman, Frank; Portnow, Jana; Batiste, James; Carroll, Nicholas; Sylvester, Albert; Campbell, Patricia; Lowy, Israel; Dolgoter, Alex; Boyer, Jean; Kraynyak, Kimberly; Morrow, Matthew P; McMullan, Trevor; Weiner, David B; Skolnik, Jeffrey; Zadeh, Gelareh; Daras, Mariza; Cloughesy, Timothy F; Colman, Howard; Kumthekar, Priya U; Chen, Clark C; Aiken, Robert; Groves, Morris D; Ong, Shirley; Ramakrishna, Rohan; Vogelbaum, Michael A; Khagi, Simon; Kaley, Thomas; Melear, Jason M; Peereboom, David M; Rodriguez, Analiz; Yankelevich, Maxim; Nair, Suresh G; Puduvalli, Vinay K; Nassiri, Farshad; Sonabend, Adam M; Agensky, Laura; Ewald, Brett; Levisetti, Matteo; Lang, Frederick F

A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer

一项评估宫颈癌放化疗后针对HPV16和HPV18 E6/E7癌基因的治疗性DNA疫苗的安全性和耐受性的I期临床试验

Hasan, Yasmin; Furtado, Larissa; Tergas, Ana; Lee, Nita; Brooks, Rebecca; McCall, Anne; Golden, Daniel; Jolly, Shruti; Fleming, Gini; Morrow, Matthew; Kraynyak, Kimberly; Sylvester, Albert; Arif, Fauzia; Levin, Matt; Schwartz, David; Boyer, Jean; Skolnik, Jeffrey; Esser, Mark; Kumar, Rakesh; Bagarazzi, Mark; Weichselbaum, Ralph; Spiotto, Michael

Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer

针对HPV16/18的免疫疗法可在HPV相关头颈癌中产生强效免疫反应

Aggarwal, Charu; Cohen, Roger B; Morrow, Matthew P; Kraynyak, Kimberly A; Sylvester, Albert J; Knoblock, Dawson M; Bauml, Joshua M; Weinstein, Gregory S; Lin, Alexander; Boyer, Jean; Sakata, Lindsay; Tan, Sophie; Anton, Aubrey; Dickerson, Kelsie; Mangrolia, Drishty; Vang, Russell; Dallas, Michael; Oyola, Sandra; Duff, Susan; Esser, Mark; Kumar, Rakesh; Weiner, David; Csiki, Ildiko; Bagarazzi, Mark L